There might be a much-coveted cure for US drug prices, analyst predicts

The rising cost of drug development, growing need for medicines with an aging population and the greater prevalence of chronic conditions, political uncertainty – many factors suggest that the problem of pricing drugs affordably is not about to away any time soon.

Yet an expert has predicted genuine confidence that two new technologies – artificial intelligence (AI) and blockchain – could not only help to bring about the arrival of more personalized treatments for patients, but also counteract the unsustainability of rising drug prices.

Valentina Gburcik, cardiovascular and metabolic disease director at the data and analytics company GlobalData, has looked in particular at how these technologies might help in the discovery phase – a critical time when decisions have to be made about whether to proceed through to clinical trials.